Illumina (ILMN) Optics for Genomics Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Illumina (ILMN) Optics for Genomics

ILMN 123.54

+24.8%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: idos	4/16/2009 2:22:51 PM
	of 276

An impressive order: Illumina shares gain ground as MIT, Harvard partnership adds 22 gene analyzing systems finance.yahoo.com NEW YORK (AP) -- Shares of genetic analysis company Illumina Inc. rose Thursday after the company said it sold 22 gene analyzing systems to the Broad Institute, boosting that institution's installed base to 47 units. The Broad Institute is a collaboration between Cambridge, Mass., neighbors Massachusetts Institute of Technology and Harvard University. It focuses on genetic research. Shares of Illumina rose $1.34, or 3.9 percent, to $35.61 in midday trading. The stock has traded between $18.82 and $47.88 over the past 52 weeks. "The Broad Institute's decision to significantly scale their installed base of Genome Analyzers is a tremendous sign of their confidence in our ability to continue improving the performance and economics of the system," said Illumina Senior Vice President and Chief Financial Officer Christian Henry, in a statement. During the first quarter, the company reported a 43 percent boost in revenue, reaching $160.9 million. The Genome Analyzer is one of its main genetic technology products.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next